U.S. to resume J&J COVID-19 vaccinations despite rare clot risk

The government uncovered 15 vaccine recipients who developed a highly unusual kind of blood clot, out of nearly 8 million people given the J&J shot

source https://www.thehindu.com/news/international/us-to-resume-jj-covid-19-vaccinations-despite-rare-clot-risk/article34398488.ece